Podcasts Health & Fitness Medicine NEJM Interviews NEJM Interview: Dr. William Feldman on a new federal price-transparency rule and legal challenges to efforts to increase access to pricing information.

NEJM Interview: Dr. William Feldman on a new federal price-transparency rule and legal challenges to efforts to increase access to pricing information.

Published: Feb. 10, 2021, 3:01 p.m.

b'Dr. William Feldman is a physician and researcher in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women\\u2019s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. W.B. Feldman and Others. The Future of Drug-Pricing Transparency. N Engl J Med 2021;384:489-491.'